European Physician Tech Tools of the Trade - Wikipedia and Social Networking?

Manhattan ResearchManhattan Research, a global healthcare and pharmaceutical market research company, today announced the release of Taking the Pulse® Europe v8.0, its European physician study and strategic advisory service. It offers in-depth market data and analysis of how physicians across Western Europe integrate the Internet and technology into their practises. Taking the Pulse® Europe also looks at key trends in pharma company/sales rep interactions and electronic detailing.

According to the study, European physicians are more reliant than ever on technology - over 80% who are online reported that the Internet is essential to their practice. On the Web 2.0 front, physician-only social networks potential is high, with nearly two-thirds of online physicians interested in joining this type of community. Also, about two-thirds of physicians online use Wikipedia as a medical resource monthly or more often - and they're even recommending it to patients.

Most Visited Physician Websites in 2008

United Kingdom - British Medical Journal (BMJ.com)

Germany - DocCheck (doccheck.com)

France - Univadis (univadis.fr)

Spain - Diario Medico (diariomedico.com)

Italy - Ministero della Salute (ministerosalute.it)

Among physicians using the Internet for professional purposes

Taking the Pulse® Europe v8.0 was fielded in Q4 2008 among 1,000 European practising physicians from the United Kingdom, Germany, Spain, Italy, and France. For more information, visit http://www.manhattanresearch.com/products/physician/EUphysicians.aspx

To download Manhattan Research's complimentary European Opinion Leader Roundtable, visit http://www.manhattanresearch.com/research/roundtables/european-roundtable-2008.aspx

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm. We conduct annual research studies covering eHealth trends among physicians and consumers in the U.S., Europe, and Asia. Broad research is complemented by targeted analysis among more than 100 consumer therapeutic segments and 25 physician specialist segments.

For information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...